Ocular Therapeutix (NASDAQ:OCUL) Releases Quarterly Earnings Results, Misses Estimates By $0.08 EPS
Ocular Therapeutix (NASDAQ:OCUL - Get Free Report) announced its earnings results on Tuesday. The biopharmaceutical company reported ($0.40) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.32) by ($0.08). The firm had revenue of $10.79 million for the quarter...